IVABRADINE ALTER 7.5 mg, tablet 56 tablets
Active ingredients: Ivabradine, Ivabradine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Tablet56 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IVABRADINE ALTER 7,5 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) polyamide aluminium PVC-Aluminium de 56 comprimé(s)
- Marketing authorisation holder
- LABORATOIRES ALTER
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 5 Nov 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65486532CIP73014081CIP133400930140819Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IVABRADINEcomprimé | 7,5 mg · un comprimé | FT |
| IVABRADINE (CHLORHYDRATE D')comprimé | 8,085 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.